Journal
BLOOD
Volume 115, Issue 2, Pages 168-186Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-06-225565
Keywords
-
Categories
Funding
- Amgen Ltd
- Baxter Ltd
- GlaxoSmithKline Ltd
Ask authors/readers for more resources
Previously published guidelines for the diagnosis and management of primary immune thrombocytopenia (ITP) require updating largely due to the introduction of new classes of therapeutic agents, and a greater understanding of the disease pathophysiology. However, treatment-related decisions still remain principally dependent on clinical expertise or patient preference rather than high-quality clinical trial evidence. This consensus document aims to report on new data and provide consensus-based recommendations relating to diagnosis and treatment of ITP in adults, in children, and during pregnancy. The inclusion of summary tables within this document, supported by information tables in the online appendices, is intended to aid in clinical decision making. (Blood. 2010; 115:168-186)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available